A phase i study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates
Adrian J Lowe*, Mimi LK Tang, Shyamali C Dharmage, George Varigos, Della Forster, Lyle C Gurrin, Colin F Robertson, Michael J Abramson, Katrina J Allen and John Su